Janus Henderson Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Janus Henderson Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,300	Closed	-$410K	–	2613
2024 Q3	$410K	Hold	12,300	–	–	﹤0.01%	2126
2024 Q2	$332K	Buy	+12,300	New	+$243K	﹤0.01%	2162

Janus Henderson Group's LBPH Position: Q4 2024 in Review

Janus Henderson Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 12,300 shares — an estimated $410K sold.

Janus Henderson Group first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $410K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Janus Henderson Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Janus Henderson Group sold 12,300 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $410K.
Janus Henderson Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Janus Henderson Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $410K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.